FAKTOR-ZERTIFIKAT - BIOGEN IDEC | Market Closed - Börse Stuttgart 15:45:37 2024-05-31 EDT | ||
| 6.24 EUR | +17.74% |
|
| Current month | +2.30% | ||
| 1 month | +2.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 6.24 | +17.74% |
| 24-05-30 | 5.3 | +11.11% |
| 24-05-29 | 4.77 | -11.01% |
| 24-05-28 | 5.36 | -0.37% |
| 24-05-27 | 5.38 | +2.28% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 03:45 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JK4CZ9 |
| ISIN | DE000JK4CZ99 |
| Date issued | 2024-03-22 |
| Strike | 188.7 $ |
| Maturity | Unlimited |
| Parity | 5.57 : 1 |
| Emission price | 10.15 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.29 € |
|---|---|
| Lowest since issue | 2.88 € |
| Spread | 0.3 € |
| Spread % | 4.57% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
224.9
USD
Average target price
284.8
USD
Spread / Average Target
+26.60%
- Stock Market
- Certificates
- Certificat
